Position in CADL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$126,949
-$3,001 QoQ
Shares Held
25,908
+12.6% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stratos Wealth Advisors, LLC holds $8,641,273 across 7 Biotechnology names. CADL ranks #5 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,695 | $6,718,104 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
20,796 | $1,174,766 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
8,022 | $266,490 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
5,365 | $255,213 | |
| 5 | CADL |
Candel Therapeutics, Inc.
This page
|
25,908 | $126,949 | |
| 6 | ABCL |
AbCellera Biologics Inc.
|
23,000 | $80,270 | |
| 7 | OSTX |
OS Therapies Inc
|
13,817 | $19,481 |
All Filings in CADL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $126,949 | 25,908 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $129,950 | 23,000 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $117,300 | 23,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $116,380 | 23,000 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $129,950 | 23,000 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||